A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
University College, London
Astellas Pharma Inc
Dana-Farber Cancer Institute
AstraZeneca
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
St. Jude Children's Research Hospital
Barbara Ann Karmanos Cancer Institute
University Hospital Southampton NHS Foundation Trust
National Cancer Institute (NCI)
Allarity Therapeutics
Merck Sharp & Dohme LLC
AstraZeneca
Celgene
University of Birmingham
US Oncology Research
National Hospital Organization Nagoya Medical Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
St. Jude Children's Research Hospital
West China Hospital
Kosin University Gospel Hospital
Innovent Biologics (Suzhou) Co. Ltd.
University of Southampton
Konkuk University Medical Center
West China Hospital
Kosin University Gospel Hospital
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Seattle Children's Hospital
Royal Marsden NHS Foundation Trust
Janssen Research & Development, LLC
Newcastle-upon-Tyne Hospitals NHS Trust
Sanofi
Children's National Research Institute
Janssen Research & Development, LLC
University College, London
University College, London
University Hospital Plymouth NHS Trust
Dong-A University Hospital
Bayer
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Arbeitsgemeinschaft medikamentoese Tumortherapie
National Cancer Institute (NCI)